HealthTech M&A deal volume has climbed to near-record highs, partially driven by COVID-19’s global spread. In 2020 the number of deals grew by 11% with 310 deals announced. Private Equity activity in the market has been steadily increasing over the last 10 years - at 36% of all deals in 2020.

 

Disclosed M&A deal value has been rising from 2013 through 2018, followed by a precipitous drop in 2019. 2020, however, saw record-high deal values, with $34.1B spent on HealthTech deals.

 

As for the top buyers, 3 PE firms – Advent, Clearlake Capital and New Mountain Capital - made 6 acquisitions each, followed by another PE – Abry Partners, strategic buyer Well Health, and others.